OKYO Pharma (OKYO) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free OKYO Stock Alerts GBX 1.40 -0.45 (-24.32%) (As of 05/19/2023) Add Compare Share Share HeadlinesStock AnalysisHeadlinesInsider TradesStock AnalysisHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOKYO Pharma (LON:OKYO) Stock Price Down 24.3%americanbankingnews.com - April 17 at 2:20 AMA second Kobayashi Pharma Japan factory inspected over deathsmsn.com - March 31 at 1:37 PMJapanese authorities inspect second Kobayashi Pharma factory after deathsmsn.com - March 31 at 1:37 PMKobayashi factory searched over deaths possibly linked to supplementsmsn.com - March 30 at 3:03 AM5 dead and over 100 hospitalized from recalled Japanese health supplementsmsn.com - March 29 at 4:34 AMWhat are 'beni-koji' products linked to Japan deaths?msn.com - March 28 at 3:31 AMA Japanese supplement pill is recalled after two people died and more than 100 were hospitalizedmsn.com - March 27 at 7:29 AMUnicycive rises 4% on $50M private placementmsn.com - March 14 at 9:33 AMPeople in Japan more worried about smell of others' excrement than their own: surveymsn.com - March 3 at 1:37 AM1 in 4 Japan primary school kids with hay fever's itchy eyes have trouble studyingmsn.com - February 23 at 7:47 PMOKYO Pharma Stock (NASDAQ:OKYO), Short Interest Reportbenzinga.com - February 22 at 12:23 AMOKYO Pharma gains on receiving FDA nod of IND for OK-101 in neuropathic corneal painmsn.com - February 9 at 4:03 PMOKYO Shares Rise 12% After FDA Clearance for IND Applicationmorningstar.com - February 9 at 11:03 AMOKYO Pharma Says Phase 2 Study Of OK-101 Did Not Meet Primary Goalmarkets.businessinsider.com - January 8 at 8:46 AMOKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024finance.yahoo.com - January 5 at 10:24 AMEyepoint Pharmaceuticals stock soars on wet-AMD trial resultsproactiveinvestors.com - December 4 at 1:00 PMOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol Visitfinance.yahoo.com - December 4 at 7:59 AMHC Wainwright & Co. Initiates Coverage of OKYO Pharma Limited - (OKYO) with Buy Recommendationmsn.com - November 3 at 1:06 AMOKYO Pharma raises $5.84m via share issuanceproactiveinvestors.com - October 31 at 12:57 PMOKYO Pharma Announces $5.84 Million Cash Raise and Payables Reductionfinanznachrichten.de - October 31 at 7:31 AMDry Eye Disease Affects Around 50M Americans, OKYO Pharma's Candidate Shows Safety In Mid-Stage Studymsn.com - October 5 at 2:11 PMOKYO shares retreat 12% after rallying ahead of Phase 2 study updatemsn.com - October 5 at 2:11 PMOKYO Pharma Reports Positive Safety Data Profile For OK-101 In Dry Eye Diseasemarkets.businessinsider.com - October 5 at 9:11 AMOKYO Pharma phase II dry eye trial making encouraging progressproactiveinvestors.com - October 5 at 9:11 AMOKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease ("DED")finance.yahoo.com - October 5 at 9:11 AMOKYO Pharma closes $4M registered direct offeringproactiveinvestors.com - September 15 at 8:38 AMOKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary Sharesfinance.yahoo.com - September 14 at 9:36 AMOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease (“DED”)uk.finance.yahoo.com - August 30 at 7:28 AMOKYO Pharma regains compliance with Nasdaq listing minimum...OKYO Pharma regains compliance with Nasdaq listing minimum market...proactiveinvestors.com - August 29 at 4:17 PMOKYO Pharma Shares Rise 15% After Regaining Nasdaq Compliancemarketwatch.com - August 29 at 4:17 PMOKYO Pharma withdraws public offerproactiveinvestors.com - August 1 at 7:00 PMStocks to Watch: Barnes & Noble Education, HomeStreet and OKYO Pharmamarketwatch.com - July 28 at 8:08 PMOKYO Pharma Limited Receives Nasdaq Deficiency Noticefinance.yahoo.com - July 28 at 8:08 PMOKYO Pharma Announces Proposed Public Offering of Ordinary Sharesfinance.yahoo.com - July 28 at 8:08 PMEye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?benzinga.com - May 30 at 12:42 PMOKYO Pharma LTD: OKYO Pharma Now Participating on the Webull Corporate Communications Service Platformfinanznachrichten.de - May 11 at 9:50 AMOKYO Pharma Now Participating on the Webull Corporate Communications Service Platformfinance.yahoo.com - May 11 at 9:50 AMGoldman Small Cap Research Publishes New Research Report on OKYO Pharma Limitedfinance.yahoo.com - May 9 at 12:43 PMOKYO Pharma reaches milestone with first patient screening for dry eye disease trialproactiveinvestors.com - May 2 at 8:14 PMOKYO Pharma screens first patient for dry eye disease trialproactiveinvestors.com - May 2 at 10:12 AMOKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Diseasefinance.yahoo.com - May 2 at 10:12 AMOKYO Pharma Limited (OKYO)ca.finance.yahoo.com - April 29 at 9:02 AMOKYO Pharma Activates First Clinical Trial Site For Phase 2 Study Of OK-101 To Treat Dry Eye Diseasebenzinga.com - April 26 at 10:10 AMLondon stock market is 'a complete waste of time': Italian biotech tycoon plans to quit the Citymsn.com - April 18 at 11:35 PMOKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Paybenzinga.com - April 18 at 8:33 AMFTSE 100 falls as oil stocks drag, pound risesreuters.com - April 4 at 1:27 PMOKYO Pharma LTD: Notice of Intention to Delist From The London Stock Exchangefinanznachrichten.de - April 4 at 8:26 AMOkyo Pharma Shares Fall on London Stock Delisting Planmarketwatch.com - April 4 at 8:26 AMOKYO Pharma plans UK de-listing in favour of US quoteproactiveinvestors.com - April 4 at 8:26 AMBanks, miners push FTSE 100 up for seventh day; OKYO Pharma slumpsmsn.com - April 4 at 8:26 AM Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Email Address $25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time… Go here to watch the most recent trading workshop video at no charge. OKYO Media Mentions By Week OKYO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OKYO News Sentiment▼0.000.44▲Average Medical News Sentiment OKYO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OKYO Articles This Week▼00▲OKYO Articles Average Week Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Hemogenyx Pharmaceuticals News Today C4X Discovery News Today Oncimmune News Today Destiny Pharma News Today Oxford BioDynamics News Today Sareum News Today OptiBiotix Health News Today Ondine Biomedical News Today Synairgen News Today ImmuPharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OKYO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OKYO Pharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
